MétaCan
Menu
Back to cohort
Record W4414465979 · doi:10.1158/2326-6074.cimm25-ia04

Abstract IA04: Reprogramming the tumor–immune microenvironment: From stromal circuits to engineered microbial immunotherapies

2025· article· en· W4414465979 on OpenAlexaboutno aff
Nicholas Arpaia

Bibliographic record

VenueCancer Immunology Research · 2025
Typearticle
Languageen
FieldEngineering
TopicNanoplatforms for cancer theranostics
Canadian institutionsnot available
Fundersnot available
KeywordsReprogrammingImmunotherapyStromal cellCancer immunotherapyTumor microenvironmentImmune systemImmune checkpointChemokine

Abstract

fetched live from OpenAlex

Abstract The gut and intratumoral microbiota are increasingly recognized as modulators of host immunity and cancer immunotherapy outcomes. Harnessing this potential, we have developed a platform for engineering probiotic bacteria into programmable immunotherapeutic agents capable of reshaping the tumor microenvironment. Using E. coli Nissle 1917, we engineered microbial therapies that locally deliver checkpoint inhibitors, cytokines, and chemokines within tumors – achieving potent immune activation without systemic toxicity. Building on this approach, we recently engineered this system to serve as a personalized neoantigen immunotherapy platform, delivering tumor-specific neoantigens directly into host cells. This strategy drives robust neoantigen-specific CD4+ and CD8+ T cell responses, reconditions the tumor microenvironment, and induces durable tumor regression in preclinical models. These studies demonstrate the potential of microbial vectors as versatile and modular platforms for enhancing immunologic fitness and therapeutic precision in solid tumors. In parallel, we are uncovering fundamental mechanisms of immune regulation within the tumor stroma, focusing on non-immune components that shape immunologic fitness. Through single-cell and spatial transcriptomics, we identified a previously unrecognized population of immunomodulatory cancer-associated fibroblasts (imCAFs) that act as key orchestrators of local immunosuppression, functioning through a chemokine signaling axis to recruit and support hyper-suppressive regulatory T cells (Tregs) at the tumor border. Genetic perturbation of this stromal–immune circuit reprograms the tumor microenvironment toward cytotoxic T cell activation and tumor control. Underscoring the clinical relevance of these findings – and highlighting a potential avenue for therapeutic intervention by targeting the stromal compartment – we also observe analogous imCAF–Treg spatial organization in human NSCLC samples, with increased expression of imCAF markers in lung tumors being associated with reduced cytotoxicity scores and decreased progression-free survival. Together, these complementary efforts highlight how microbial engineering and stromal immunobiology can be integrated to uncover new therapeutic strategies and mechanistic insights. By leveraging synthetic biology, spatial omics, and immunoengineering, this work aims to define and modulate the determinants of immunologic fitness in solid tumors, with the ultimate goal of developing precise, effective, and durable cancer immunotherapies. Citation Format: Nicholas Arpaia. Reprogramming the tumor–immune microenvironment: From stromal circuits to engineered microbial immunotherapies [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity; 2025 Sep 24-27; Montreal, QC, Canada. Philadelphia (PA): AACR; Cancer Immunol Res 2025;13(9 Suppl):Abstract nr IA04.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.183
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.289
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer Immunology ResearchSame topicNanoplatforms for cancer theranosticsFrench-language works237,207